BioMarin Pharmaceutical Inc.
BMRN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $942,842 | $755,127 | $724,531 | $587,276 |
| Short-Term Investments | $194,864 | $318,683 | $567,006 | $426,599 |
| Receivables | $660,535 | $633,704 | $461,316 | $373,399 |
| Inventory | $1,232,653 | $1,107,183 | $894,083 | $776,669 |
| Other Curr. Assets | $201,533 | $141,391 | $104,521 | $110,442 |
| Total Curr. Assets | $3,232,427 | $2,956,088 | $2,751,457 | $2,274,385 |
| Property Plant & Equip (Net) | $1,043,041 | $1,066,133 | $1,073,366 | $1,035,461 |
| Goodwill | $196,199 | $196,199 | $196,199 | $196,199 |
| Intangibles | $255,278 | $294,701 | $338,569 | $388,652 |
| Long-Term Investments | $521,238 | $611,135 | $333,835 | $507,793 |
| Tax Assets | $1,489,366 | $1,545,809 | $1,505,412 | $1,450,161 |
| Other NC Assets | $251,391 | $171,538 | $176,236 | $152,121 |
| Total NC Assets | $3,756,513 | $3,885,515 | $3,623,617 | $3,730,387 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $6,988,940 | $6,841,603 | $6,375,074 | $6,004,772 |
| Liabilities | – | – | – | – |
| Payables | $235,403 | $315,509 | $231,238 | $199,678 |
| Short-Term Debt | $23,071 | $502,656 | $10,375 | $10,464 |
| Tax Payable | $12,567 | $2,651 | $16,213 | $1,213 |
| Deferred Revenue | $1,369 | $4,620 | $711 | $6,956 |
| Other Curr. Liab. | $334,578 | $351,588 | $330,347 | $328,186 |
| Total Curr. Liab. | $606,988 | $1,177,024 | $588,884 | $546,497 |
| LT Debt | $626,395 | $593,095 | $1,083,019 | $1,079,077 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $97,567 | $119,935 | $100,015 | $113,529 |
| Total NC Liab. | $723,962 | $713,030 | $1,183,034 | $1,192,606 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $31,257 | $8,779 | $10,375 | $10,464 |
| Total Liabilities | $1,330,950 | $1,890,054 | $1,771,918 | $1,739,103 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $191 | $189 | $186 | $184 |
| Retained Earnings | -$194,695 | -$621,554 | -$789,199 | -$930,760 |
| AOCI | $61,653 | -$28,788 | -$3,867 | $14,432 |
| Other Equity | $5,790,841 | $5,601,702 | $5,396,036 | $5,181,813 |
| Total Equity | $5,657,990 | $4,951,549 | $4,603,156 | $4,265,669 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $6,988,940 | $6,841,603 | $6,375,074 | $6,004,772 |
| Net Debt | -$293,376 | $340,624 | $368,863 | $502,265 |